Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2009; 134(34/35): 1688-1691
DOI: 10.1055/s-0029-1234003
DOI: 10.1055/s-0029-1234003
Übersicht | Review article
Nephrologie, Immunologie
© Georg Thieme Verlag KG Stuttgart · New York
Bone Morphogenic Protein-7 (BMP7) und die Niere
Einblicke in die Zukunft der Therapie chronischer NierenerkrankungenBone Morphogenic Protein-7 (BMP7) and the kidneysInsights into the future management of chronic kidney diseasesFurther Information
Publication History
eingereicht: 22.5.2009
akzeptiert: 9.7.2009
Publication Date:
25 August 2009 (online)
Schlüsselwörter
chronische Niereninsuffizienz - Fibrose - Bone Morphogenic Protein
Keywords
chronic kidney disease - fibrosis - Bone Morphogenic Protein
Literatur
- 1 Bahlmann F H, Kielstein J T, Haller H, Fliser D. Erythropoietin and progression of CKD. Kidney int. 2007; Suppl S21-25
- 2 Bohle A, Christ H, Grund K E, Mackensen S. The role of the interstitium of the renal cortex in renal disease. Contrib Nephrol. 1979; 16 109-114
- 3 Boor P, Sebekova K, Ostendorf T, Floege J. Treatment targets in renal fibrosis. Nephrol Dial Transplant. 2007; 22 3391-3407
- 4 Border W A, Noble N A. Transforming growth factor beta in tissue fibrosis. New Engl J Med. 1994; 331 1286-1292
- 5 Derynck R, Gelbart W M, Harland R M. et al . Nomenclature: vertebrate mediators of TGFbeta family signals. Cell. 1996; 87 173
- 6 Dolan V, Murphy M, Sadlier D. et al . Expression of gremlin, a bone morphogenetic protein antagonist, in human diabetic nephropathy. Am J Kidney Dis. 2005; 45 1034-1039
- 7 Dudley A T, Lyons K M, Robertson E J. A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes & Development. 1995; 9 2795-2807
- 8 Eknoyan G, Lameire N, Barsoum R. et al . The burden of kidney disease: improving global outcomes. Kidney int. 2004; 66 1310-1314
- 9 Floege J, Grone H J. Progression of renal failure: what is the role of cytokines?. Nephrol Dial Transplant. 1995; 10 1575-1586
- 10 Hogan B L. Bone morphogenetic proteins in development. Current Opinion Genet Development. 1996; 6 432-438
- 11 Hugo C. The thrombospondin 1-TGF-beta axis in fibrotic renal disease. Nephrol Dial Transplant. 2003; 18 1241-1245
- 12 Kalluri R, Zeisberg M. Exploring the connection between chronic renal fibrosis and bone morphogenic protein-7. Histol Histopathol. 2003; 18 217-224
- 13 Kazama I, Mahoney Z, Miner J H. et al . Podocyte-derived BMP7 is critical for nephron development. J Am Soc Nephrol. 2008; 19 2181-2191
- 14 Lin J, Patel S R, Cheng X. et al . Kielin/chordin-like protein, a novel enhancer of BMP signaling, attenuates renal fibrotic disease. Nat Med. 2005; 11 387-393
- 15 Luo G, Hofmann C, Bronckers A L. et al . BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Development. 1995; 9 2808-2820
- 16 Maric I, Poljak L, Zoricic S. et al . Bone morphogenetic protein-7 reduces the severity of colon tissue damage and accelerates the healing of inflammatory bowel disease in rats. J cell Physiol. 2003; 196 258-264
- 17 Ozkaynak E, Schnegelsberg P N, Oppermann H. Murine osteogenic protein (OP-1): high levels of mRNA in kidney. Biochem Biophysical Res Commun. 1991; 179 116-123
- 18 Panzer U, Steinmetz O M, Stahl R A, Wolf G. Kidney diseases and chemokines. Current Drug Targets. 2006; 7 65-80
- 19 Peters H, Border W A, Noble N A. Targeting TGF-beta overexpression in renal disease: maximizing the antifibrotic action of angiotensin II blockade. Kidney int. 1998; 54 1570-1580
- 20 Roxburgh S A, Kattla J J, Curran S P. et al . Allelic depletion of grem1 attenuates diabetic kidney disease. Diabetes. 2009; 58 1641-1650
- 21 Sampath T K, Maliakal J C, Hauschka P V. et al . Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J biolog Chem. 1992; 267 20 352-20 362
- 22 Schaefer L, Macakova K, Raslik I. et al . Absence of decorin adversely influences tubulointerstitial fibrosis of the obstructed kidney by enhanced apoptosis and increased inflammatory reaction. Amer J Pathol. 2002; 160 1181-1191
- 23 Simon M, Maresh J G, Harris S E. et al . Expression of bone morphogenetic protein-7 mRNA in normal and ischemic adult rat kidney. The American journal of physiology. 1999; 276 F382-389
- 24 Sterzel R B, Hartner A, Hilgers K F, Bressan G M. Contribution of the mesangium to elastic strength and anchorage of the glomerular capillary tuft. Contribut Nephrol. 2001; 131 132-141
- 25 Strutz F, Muller G A. Interstitial pathomechanisms underlying progressive tubulointerstitial damage. Kidney Blood Press Res. 1999; 22 71-80
- 26 Strutz F, Zeisberg M, Renziehausen A. et al . TGF-beta1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2). Kidney international. 2001; 59 579-592
- 27 Sugimoto H, Grahovac G, Zeisberg M, Kalluri R. Renal fibrosis and glomerulosclerosis in a new mouse model of diabetic nephropathy and its regression by bone morphogenic protein-7 and advanced glycation end product inhibitors. Diabetes. 2007; 56 1825-1833
- 28 Swencki-Underwood B, Mills J K, Vennarini J. et al . Expression and characterization of a human BMP-7 variant with improved biochemical properties. Protein Expression Purification. 2008; 57 312-319
- 29 Tamaki K, Souchelnytskyi S, Itoh S. et al . Intracellular signaling of osteogenic protein-1 through Smad5 activation. Journal of cellular physiology. 1998; 177 355-363
- 30 Tonelli M, Wiebe N, Culleton B. et al . Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006; 17 2034-2047
- 31 Urist M R. Bone: formation by autoinduction. Science. 1965; 150 893-899
- 32 Vukicevic S, Basic V, Rogic D. et al . Osteogenic protein-1 (bone morphogenetic protein-7) reduces severity of injury after ischemic acute renal failure in rat. J clin invest. 1998; 102 202-214
- 33 Wang S, Chen Q, Simon T C. et al . Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy. Kidney int. 2003; 63 2037-2049
- 34 Wang S N, Lapage J, Hirschberg R. Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy. J Am Soc Nephrol. 2001; 12 2392-2399
- 35 Wolf G, Ritz E. Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications. Kidney int. 2005; 67 799-812
- 36 Wolf G, Zahner G, Schroeder R, Stahl R A. Transforming growth factor beta mediates the angiotensin-II-induced stimulation of collagen type IV synthesis in cultured murine proximal tubular cells. Nephrol Dial Transplant. 1996; 11 263-269
- 37 Yanagita M, Oka M, Watabe T. et al . USAG-1: a bone morphogenetic protein antagonist abundantly expressed in the kidney. Biochem biophys Res Commun. 2004; 316 490-500
- 38 Zeisberg E M, Tarnavski O, Zeisberg M. et al . Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med. 2007; 13 952-961
- 39 Zeisberg M, Bottiglio C, Kumar N. et al . Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models. Am J Physiol Renal Physiol. 2003; 285 F1060-1067
- 40 Zeisberg M, Hanai J, Sugimoto H. et al . BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med. 2003; 9 964-968
- 41 Zeisberg M, Kalluri R. Experimental strategies to reverse chronic renal disease. Blood purification. 2004; 22 440-445
- 42 Zeisberg M, Kalluri R. The role of epithelial-to-mesenchymal transition in renal fibrosis. J Mol Med. 2004; 82 175-181
- 43 Zeisberg M, Muller G A, Kalluri R. Are there endogenous molecules that protect kidneys from injury? The case for bone morphogenic protein-7 (BMP-7). Nephrol Dial Transplant. 2004; 19 759-761
- 44 Zeisberg M, Strutz F, Muller G A. Renal fibrosis: an update. Curr Opin Nephrol Hypertens. 2001; 10 315-320
- 45 Zeisberg M, Yang C, Martino M. et al . Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J biol Chem. 2007; 282 23337-23347
- 46 Zeisberg M. Bone morphogenic protein-7 and the kidney: current concepts and open questions. Nephrol Dial Transplant. 2006; 21 568-573
Dr. Michael Zeisberg
Assistant Professor of Medicine, Division of
Matrix Biology, Beth Israel Deaconess Medical
Center, Harvard Medical School
330 Brookline Avenue,
RW763C
Boston, MA 02215
Phone: +1-617/667-3583
Fax: +1-617/667-0360
Email: mzeisber@bidmc.harvard.edu